Guest Post by David Kliff, Editor, Diabetic Investor Never let it said that this wacky world is devoid of some strange facts. Back in the day, it was discovered that exenatide was derived from Gila Monster saliva. Today GLP-1 therapy is one of the fastest growing segments of the diabetes drug market.

Please select the drug class that best fits the description. This drug class is universally effective at reducing plasma glucose levels: 1. DPP-4 inhibitors 2. SGLT-2 Agonists 3. Dopamine-2 Agonists 4. Insulin Did you get it right? Follow the link to find out!

When do you think there might be a cure for type 1 diabetes? 1. Less than 5 years 2. Less than 8 years 3. Less than 10 years 4. More than 10 years Follow the link to share your opinion and see what your colleagues think.

Male, 56 years of age, type 2 dm, hypertension with orthostatic hypotension, peripheral neuropathy, hyperlipidemia, class II obesity. He fills his pill box every month and has been doing so for years. It has taken some time, but we finally came up with a plan with his meds and lifestyle where he has been feeling very well and his numbers are better than ever. He filled his med box a week before contacting me. He wasn’t feeling well. Feeling dizzy and his legs were feeling like rubber.

In this week's Homerun Slides: EMPA-REG Outcome Trial Part 1: Meta-analysis of intensive glucose control in T2DM.

Central nervous effects: A role for GLP-1 in the central nervous regulation of food intake has been inferred from the high density of GLP-1 receptors in the hypothalamus. Also, direct intracerebroventricular administration of GLP-1 has caused a significant reduction in food intake in rats, and these actions could be abolished by co-administration of the GLP-1 receptor antagonist exendin.

IDegLira, LixiLan go head-to-head; FDA approves Novo Nordisk’s Xultophy and Sanofi’s Soliqua on the same day.

Therapy shows neutral CV benefit, increases bleeding risk in type 2 diabetes.

Study finds treatment on top of stable renin angiotensin system (RAS)-inhibition decreased risk.

Study shows death rate more than five times higher than in those without the disease.